Article Text

Download PDFPDF
Evaluating residual anti-Xa levels following discontinuation of treatment-dose enoxaparin in patients presenting for elective surgery: an infographic

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

PDF extract preview

You do not have access to the full text of this article, the first page of the PDF of this article appears above.


  • Twitter @ESchwenkMD, @dr_rajgupta

  • Contributors All authors contributed to the concept and design and editing of the infographic. DSH is the lead author of the original manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests RKG and ESS are co-associate editors for social media in Regional Anesthesia and Pain Medicine. ESS is an editor for Regional Anesthesia and Pain Medicine. RKG is a Director-at-Large for the American Society of Regional Anesthesia and Pain Medicine Board of Directors.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles